|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/46 | |
| C07K 16/30 | |||
| C07K 14/56 | |||
| A61K 39/395 | |||
| A61K 38/21 | |||
| A61K 31/454 | |||
| A61P 35/00 | |||
| A61K 45/06 | |||
| C07K 16/28 | |||
| A61K 47/68 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3137505 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15799475.7 |
| Europos patento paraiškos padavimo data | 2015-05-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/001600 |
| Data | 2015-05-01 |
| (87) | Numeris | WO 2015/181641 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 201461986913 P | 2014-05-01 | US |
| (72) |
POGUE, Sarah L., US
WILSON, David S., US
DOYLE, Anthony Gerard, AU
BEHRENS, Collette Jane, AU
|
| (73) |
Teva Pharmaceuticals Australia Pty Ltd,
Level 2 37 Epping Road, Macquarie Park, NSW 2113,
AU
|
| (54) | COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THEREOF |
| COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THEREOF |